Treatment horizon in multiple myeloma.
Eur J Haematol
; 109(5): 425-440, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-35880395
ABSTRACT
OBJECTIVES:
This paper reviews current and emerging therapies for multiple myeloma (MM).METHODS:
Narrative review.RESULTS:
MM is a complex, heterogenous condition, and in recent years there has been an expansion in the number and range of treatments. Several new treatment approaches, including enhanced monoclonal antibodies, antibody-drug conjugates, bispecific T-cell engagers, and chimeric antigen-T-cell therapy are under development.CONCLUSIONS:
The emergence of new treatments that aim to tackle MM-associated immune dysfunction has led to improvements in overall survival.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Inmunoconjugados
/
Mieloma Múltiple
Límite:
Humans
Idioma:
En
Revista:
Eur J Haematol
Asunto de la revista:
HEMATOLOGIA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Singapur